BenzoyleneureaCAS# 86-96-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 86-96-4 | SDF | Download SDF |
PubChem ID | 64048 | Appearance | Powder |
Formula | C8H6N2O2 | M.Wt | 162 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 1H-quinazoline-2,4-dione | ||
SMILES | C1=CC=C2C(=C1)C(=O)NC(=O)N2 | ||
Standard InChIKey | SDQJTWBNWQABLE-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C8H6N2O2/c11-7-5-3-1-2-4-6(5)9-8(12)10-7/h1-4H,(H2,9,10,11,12) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Benzoyleneurea Dilution Calculator
Benzoyleneurea Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 6.1728 mL | 30.8642 mL | 61.7284 mL | 123.4568 mL | 154.321 mL |
5 mM | 1.2346 mL | 6.1728 mL | 12.3457 mL | 24.6914 mL | 30.8642 mL |
10 mM | 0.6173 mL | 3.0864 mL | 6.1728 mL | 12.3457 mL | 15.4321 mL |
50 mM | 0.1235 mL | 0.6173 mL | 1.2346 mL | 2.4691 mL | 3.0864 mL |
100 mM | 0.0617 mL | 0.3086 mL | 0.6173 mL | 1.2346 mL | 1.5432 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Carbazole
Catalog No.:BCN6903
CAS No.:86-74-8
- Anemosapogenin
Catalog No.:BCN2454
CAS No.:85999-40-2
- BMS-690514
Catalog No.:BCC1430
CAS No.:859853-30-8
- FIT
Catalog No.:BCC7082
CAS No.:85951-63-9
- GR 125487 sulfamate
Catalog No.:BCC7142
CAS No.:859502-43-5
- AGN 205728
Catalog No.:BCC5418
CAS No.:859498-05-8
- Acetyl meldrum's acid
Catalog No.:BCC8805
CAS No.:85920-63-4
- 4-O-Methylhonokiol
Catalog No.:BCN8474
CAS No.:68592-15-4
- 6-Iodonordihydrocapsaicin
Catalog No.:BCC5860
CAS No.:859171-97-4
- Lincomycin hydrochloride
Catalog No.:BCC9011
CAS No.:859-18-7
- prim-O-Glucosylangelicain
Catalog No.:BCN4409
CAS No.:85889-15-2
- 1,3-Dipropyl-8-phenylxanthine
Catalog No.:BCC6664
CAS No.:85872-53-3
- Cyclovirobuxine
Catalog No.:BCN5965
CAS No.:860-79-7
- AZD7762
Catalog No.:BCC2555
CAS No.:860352-01-8
- Fmoc-Cys(Acm)-OH
Catalog No.:BCC3473
CAS No.:86060-81-3
- Fmoc-Lys(Z)-OH
Catalog No.:BCC3525
CAS No.:86060-82-4
- Fmoc-Asp-OBzl
Catalog No.:BCC3087
CAS No.:86060-83-5
- Fmoc-Gly-OPfp
Catalog No.:BCC3499
CAS No.:86060-85-7
- Fmoc-Ala-OPfp
Catalog No.:BCC3035
CAS No.:86060-86-8
- Fmoc-Val-OPfp
Catalog No.:BCC3571
CAS No.:86060-87-9
- Fmoc-Leu-OPfp
Catalog No.:BCC3510
CAS No.:86060-88-0
- Fmoc-Ile-OPfp
Catalog No.:BCC3506
CAS No.:86060-89-1
- Fmoc-Pro-OPfp
Catalog No.:BCC3539
CAS No.:86060-90-4
- Fmoc-Phe-OPfp
Catalog No.:BCC3536
CAS No.:86060-92-6
Design, synthesis, and evaluation of potent and selective benzoyleneurea-based inhibitors of protein geranylgeranyltransferase-I.[Pubmed:15653335]
Bioorg Med Chem. 2005 Feb 1;13(3):677-88.
A series of novel protein geranylgeranyltransferase-I (PGGTase-I) inhibitors based on a Benzoyleneurea scaffold has been synthesized. Using a Benzoyleneurea scaffold as a mimetic for the central dipeptide (AA), we have developed CAAX peptidomimetic inhibitors that selectively block the activity of PGGTase-I over the closely related enzyme protein farnesyltransferase. In this new class of PGGTase-I inhibitors, compound (6c) with X=L-phenylalanine, displayed the highest inhibition activity against PGGTase-I with an IC50 value of 170 nM. The inhibitors described in this study represent novel and promising leads for the development of potent and selective inhibitors of mammalian PGGTase-I for potential application as antitumor agents.